Works by Ménétrier-Caux, Christine

Results: 21
    1

    Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.

    Published in:
    Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1859, doi. 10.3390/jcm8111859
    By:
    • Bossennec, Marion;
    • Rodriguez, Céline;
    • Hubert, Margaux;
    • Di-Roio, Anthony;
    • Machon, Christelle;
    • Guitton, Jérôme;
    • Battiston-Montagne, Priscilla;
    • Couturier, Mathilde;
    • Marotte, Hubert;
    • Caux, Christophe;
    • Coury, Fabienne;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    2

    Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.

    Published in:
    Breast Cancer: Targets & Therapy, 2023, v. 15, p. 311, doi. 10.2147/BCTT.S400055
    By:
    • Mery, Benoîte;
    • Ménétrier-Caux, Christine;
    • Montané, Laure;
    • Heudel, Pierre-Etienne;
    • Ray-Coquard, Isabelle;
    • Bachelot, Thomas;
    • Derbel, Olfa;
    • Augereau, Paule;
    • Treilleux, Isabelle;
    • Berthet, Justine;
    • Nkodia, Axelle;
    • Bardin-Dit-Courageot, Christine;
    • Attignon, Valery;
    • Ferrari, Anthony;
    • Garin, Gwenaele;
    • Perol, David;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Trédan, Olivier
    Publication type:
    Article
    3

    Targeting regulatory T cells.

    Published in:
    Targeted Oncology, 2012, v. 7, n. 1, p. 15, doi. 10.1007/s11523-012-0208-y
    By:
    • Ménétrier-Caux, Christine;
    • Curiel, Tyler;
    • Faget, Julien;
    • Manuel, Manuarii;
    • Caux, Christophe;
    • Zou, Weiping
    Publication type:
    Article
    4

    CD163<sup>+</sup> tumor‐associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes.

    Published in:
    Clinical & Translational Immunology, 2020, v. 9, n. 2, p. 1, doi. 10.1002/cti2.1108
    By:
    • Ramos, Rodrigo Nalio;
    • Rodriguez, Céline;
    • Hubert, Margaux;
    • Ardin, Maude;
    • Treilleux, Isabelle;
    • Ries, Carola H;
    • Lavergne, Emilie;
    • Chabaud, Sylvie;
    • Colombe, Amélie;
    • Trédan, Olivier;
    • Guedes, Henrique Gomes;
    • Laginha, Fábio;
    • Richer, Wilfrid;
    • Piaggio, Eliane;
    • Barbuto, José Alexandre M;
    • Caux, Christophe;
    • Ménétrier‐Caux, Christine;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    5

    Modulation of blood T cell polyfunctionality and HVEM/BTLA expression are critical determinants of clinical outcome in anti-PD1-treated metastatic melanoma patients.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2024.2372118
    By:
    • Dalle, Stéphane;
    • Verronese, Estelle;
    • N'Kodia, Axelle;
    • Bardin, Christine;
    • Rodriguez, Céline;
    • Andrieu, Thibault;
    • Eberhardt, Anais;
    • Chemin, Gabriel;
    • Hasan, Uzma;
    • Le-Bouar, Myrtille;
    • Caramel, Julie;
    • Amini-Adle, Mona;
    • Bendriss-Vermare, Nathalie;
    • Dubois, Bertrand;
    • Caux, Christophe;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    6
    7

    MDR1 in immunity: friend or foe?

    Published in:
    OncoImmunology, 2018, v. 7, n. 12, p. 1, doi. 10.1080/2162402X.2018.1499388
    By:
    • Bossennec, Marion;
    • Di Roio, Anthony;
    • Caux, Christophe;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    8
    9
    10

    Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.

    Published in:
    OncoImmunology, 2012, v. 1, n. 4, p. 432, doi. 10.4161/onci.19545
    By:
    • Manuel, Manuarii;
    • Trédan, Olivier;
    • Bachelot, Thomas;
    • Clapisson, Gilles;
    • Courtier, Anais;
    • Parmentier, Gilles;
    • Rabeony, Tioka;
    • Grives, Audrey;
    • Perez, Solène;
    • Mouret, Jean-François;
    • Perol, David;
    • Chabaud, Sylvie;
    • Ray-Coquard, Isabelle;
    • Labidi-Galy, Intidhar;
    • Heudel, Pierre;
    • Pierga, Jean-Yves;
    • Caux, Christophe;
    • Blay, Jean-Yves;
    • Pasqual, Nicolas;
    • Ménétrier-Caux, Christine
    Publication type:
    Article
    11
    12
    13

    Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells.

    Published in:
    International Journal of Cancer, 2013, v. 133, n. 3, p. 771, doi. 10.1002/ijc.28072
    By:
    • Sisirak, Vanja;
    • Vey, Nelly;
    • Goutagny, Nadège;
    • Renaudineau, Sarah;
    • Malfroy, Marine;
    • Thys, Sandra;
    • Treilleux, Isabelle;
    • Labidi‐Galy, Sana Intidhar;
    • Bachelot, Thomas;
    • Dezutter‐Dambuyant, Colette;
    • Ménétrier‐Caux, Christine;
    • Blay, Jean‐Yves;
    • Caux, Christophe;
    • Bendriss‐Vermare, Nathalie
    Publication type:
    Article
    14
    15
    16

    Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.

    Published in:
    BMC Cancer, 2011, v. 11, n. 1, p. 213, doi. 10.1186/1471-2407-11-213
    By:
    • Cassier, Philippe A.;
    • Treilleux, Isabelle;
    • Bachelot, Thomas;
    • Ray-Coquard, Isabelle;
    • Bendriss-Vermare, Nathalie;
    • Ménétrier-Caux, Christine;
    • Trédan, Olivier;
    • Goddard-Léon, Sophie;
    • Pin, Jean-Jacques;
    • Mignotte, Hervé;
    • Bathélémy-Dubois, Clarisse;
    • Caux, Christophe;
    • Lebecque, Serge;
    • Blay, Jean-Yves
    Publication type:
    Article
    17
    18

    The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.

    Published in:
    Science Translational Medicine, 2024, v. 16, n. 731, p. 1, doi. 10.1126/scitranslmed.add1834
    By:
    • Voissière, Aurélien;
    • Gomez-Roca, Carlos;
    • Chabaud, Sylvie;
    • Rodriguez, Céline;
    • Nkodia, Axelle;
    • Berthet, Justine;
    • Montane, Laure;
    • Bidaux, Anne-Sophie;
    • Treilleux, Isabelle;
    • Eberst, Lauriane;
    • Terret, Catherine;
    • Korakis, Iphigénie;
    • Garin, Gwenaelle;
    • Pérol, David;
    • Delord, Jean-Pierre;
    • Caux, Christophe;
    • Dubois, Bertrand;
    • Ménétrier-Caux, Christine;
    • Bendriss-Vermare, Nathalie;
    • Cassier, Philippe A.
    Publication type:
    Article
    19

    Third‐Generation CD73 Inhibitors Based on a 4,6‐Disubstituted‐2‐Thiopyridine Scaffold.

    Published in:
    ChemMedChem, 2025, v. 20, n. 6, p. 1, doi. 10.1002/cmdc.202400662
    By:
    • Grosjean, Félix;
    • Shaldaeva, Maria;
    • Cros‐Perrial, Emeline;
    • Rodriguez, Céline;
    • Ghoteimi, Rayane;
    • Lebrun, Aurélien;
    • Gao, Zhan‐Guo;
    • Uttaro, Jean‐Pierre;
    • Mathé, Christophe;
    • Jacobson, Kenneth A.;
    • Petter Jordheim, Lars;
    • Ménétrier‐Caux, Christine;
    • Chaloin, Laurent;
    • Peyrottes, Suzanne
    Publication type:
    Article
    20
    21